DK1062341T3 - Muterede rekombinante allergener - Google Patents
Muterede rekombinante allergenerInfo
- Publication number
- DK1062341T3 DK1062341T3 DK99907345T DK99907345T DK1062341T3 DK 1062341 T3 DK1062341 T3 DK 1062341T3 DK 99907345 T DK99907345 T DK 99907345T DK 99907345 T DK99907345 T DK 99907345T DK 1062341 T3 DK1062341 T3 DK 1062341T3
- Authority
- DK
- Denmark
- Prior art keywords
- allergens
- recombinant allergens
- mutant recombinant
- disclosed
- recombinant
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title abstract 7
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK36498 | 1998-03-16 | ||
PCT/DK1999/000136 WO1999047680A1 (fr) | 1998-03-16 | 1999-03-16 | Allergenes recombines mutants |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1062341T3 true DK1062341T3 (da) | 2008-11-03 |
Family
ID=8092687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99907345T DK1062341T3 (da) | 1998-03-16 | 1999-03-16 | Muterede rekombinante allergener |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040091500A1 (fr) |
EP (1) | EP1062341B1 (fr) |
JP (1) | JP2002506648A (fr) |
KR (1) | KR20010041918A (fr) |
CN (1) | CN1332029C (fr) |
AT (1) | ATE408690T1 (fr) |
AU (1) | AU749749B2 (fr) |
CA (1) | CA2323687C (fr) |
DE (1) | DE69939584D1 (fr) |
DK (1) | DK1062341T3 (fr) |
ES (1) | ES2313776T3 (fr) |
HK (1) | HK1033591A1 (fr) |
HU (1) | HUP0101464A3 (fr) |
IL (2) | IL138339A0 (fr) |
NO (1) | NO328354B1 (fr) |
NZ (1) | NZ506665A (fr) |
PL (1) | PL194804B1 (fr) |
PT (1) | PT1062341E (fr) |
WO (1) | WO1999047680A1 (fr) |
ZA (1) | ZA200004819B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2588756T3 (es) * | 2000-04-28 | 2016-11-04 | Novozymes A/S | Variante de enzima lipolítica |
IT1318692B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti di proteine allergeniche di phleum pratense. |
IT1318690B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti dell'allergene maggiore par j 2 di parietaria judaica. |
DK1340085T3 (da) * | 2000-10-17 | 2008-12-01 | Besst Test Aps | Assay til direkte detektion af en biologisk celle i en legemsvæskepröve |
MXPA03004174A (es) * | 2000-11-16 | 2004-12-02 | Alk Abello As | Alergenos mutantes novedosos. |
ATE347376T1 (de) * | 2000-12-28 | 2006-12-15 | Biomay Prod & Handel | Behandlung von allergien |
DK1499349T3 (da) * | 2001-03-02 | 2010-04-06 | Univ Rockefeller | Rekombinante hybrid-allergenkonstrukter med reduceret allergenitet, der bibeholder det naterulige allergens immunogenitet |
EP1436627A2 (fr) * | 2001-10-05 | 2004-07-14 | Novozymes A/S | Equipement permettant de prevoir la liaison d'un anticorps specifique a un immunogene potentiel, et methode de criblage |
PL212139B1 (pl) * | 2002-05-16 | 2012-08-31 | Alk Abello As | Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja zawierająca dwa lub więcej wariantów zrekombinowanych zmutowanych alergenów, zastosowanie takiej kompozycji, kompozycja farmaceutyczna zawierająca zrekombinowany alergen lub wymienioną kompozycję, zastosowanie zrekombinowanego alergenu, kompozycji lub kompozycji farmaceutycznej, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sposób przygotowania biblioteki zrekombinowanego alergenu, sekwencja DNA kodująca zrekombinowany alergen, wektor ekspresyjny obejmujący wymienione DNA, komórka gospodarza zawierająca taki wektor ekspresyjny, sposób produkcji zrekombinowanego mutanta alergenu, oraz oznaczenie diagnostyczne do oceny odpowiedniości, bezpieczeństwa lub wyniku terapii |
CN1714153A (zh) * | 2002-11-01 | 2005-12-28 | 阿尔克-阿贝洛有限公司 | 重组蛋白质变异体 |
WO2004047793A1 (fr) | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Produit pharmaceutique comprenant des allergenes |
US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
CA2516291C (fr) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Forme de dosage presentant une matrice en saccharide |
RU2006126051A (ru) | 2003-12-19 | 2008-01-27 | Альк-Абелло А/С (Dk) | Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта |
AU2006299310A1 (en) | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
ITMI20052517A1 (it) | 2005-12-29 | 2007-06-30 | Lofarma Spa | Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa |
WO2007123488A1 (fr) * | 2006-04-20 | 2007-11-01 | National University Of Singapore | Lactobacillus recombiné et utilisation de celui-ci |
ES2527412T3 (es) * | 2007-02-15 | 2015-01-23 | Mannkind Corporation | Método para aumentar la respuesta de los linfocitos T |
EP1974746B1 (fr) | 2007-03-28 | 2012-01-11 | Alk-Abelló A/S | Utilisation de formule adjuvante de vaccin contre les allergies pour administration parentérale |
EP2028188A1 (fr) * | 2007-08-21 | 2009-02-25 | Biomay AG | Molécules hypoallergéniques |
DE202008006598U1 (de) | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
EP2442828B1 (fr) | 2009-06-19 | 2016-08-03 | Alk-Abelló S.A. | Nouveau procédé d'administration d'allergène dans une immunothérapie spécifique allergénique |
CN102584966A (zh) * | 2011-11-14 | 2012-07-18 | 广州医学院第二附属医院 | 一种重组花生过敏原与突变体及其制备方法和应用 |
CN102617719A (zh) * | 2012-03-30 | 2012-08-01 | 广州医学院第二附属医院 | 一种重组大米过敏原与突变体及其制备方法和应用 |
CN102690340A (zh) * | 2012-03-30 | 2012-09-26 | 广州医学院第二附属医院 | 一种重组巴西坚果过敏原与突变体及其制备方法和应用 |
CN102603879A (zh) * | 2012-03-30 | 2012-07-25 | 广州医学院第二附属医院 | 一种重组大豆过敏原与突变体及其制备方法和应用 |
CN102617715A (zh) * | 2012-03-30 | 2012-08-01 | 广州医学院第二附属医院 | 一种重组真菌主要过敏原与突变体及其制备方法和应用 |
CN102675439A (zh) * | 2012-03-31 | 2012-09-19 | 广州医学院第二附属医院 | 一种重组黑麦草花粉过敏原与突变体的制备方法和应用 |
EP2952200A1 (fr) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergène pour le traitement prophylactique d'une allergie |
CN111187606B (zh) * | 2020-02-25 | 2022-06-14 | 江苏海洋大学 | 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804201A (en) * | 1996-03-11 | 1998-09-08 | The Rockefeller University | Immunomodulatory peptides of vespid antigen 5 |
AU743647B2 (en) * | 1998-01-31 | 2002-01-31 | Mt. Sinai School Of Medicine Of New York University | Methods and reagents for decreasing allergic reactions |
IT1318692B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti di proteine allergeniche di phleum pratense. |
-
1999
- 1999-03-16 DE DE69939584T patent/DE69939584D1/de not_active Expired - Lifetime
- 1999-03-16 NZ NZ506665A patent/NZ506665A/en not_active IP Right Cessation
- 1999-03-16 KR KR1020007010225A patent/KR20010041918A/ko not_active Application Discontinuation
- 1999-03-16 DK DK99907345T patent/DK1062341T3/da active
- 1999-03-16 CA CA002323687A patent/CA2323687C/fr not_active Expired - Fee Related
- 1999-03-16 JP JP2000536863A patent/JP2002506648A/ja active Pending
- 1999-03-16 IL IL13833999A patent/IL138339A0/xx unknown
- 1999-03-16 WO PCT/DK1999/000136 patent/WO1999047680A1/fr active IP Right Grant
- 1999-03-16 EP EP99907345A patent/EP1062341B1/fr not_active Revoked
- 1999-03-16 HU HU0101464A patent/HUP0101464A3/hu unknown
- 1999-03-16 AT AT99907345T patent/ATE408690T1/de active
- 1999-03-16 ES ES99907345T patent/ES2313776T3/es not_active Expired - Lifetime
- 1999-03-16 AU AU27147/99A patent/AU749749B2/en not_active Ceased
- 1999-03-16 CN CNB998040312A patent/CN1332029C/zh not_active Expired - Fee Related
- 1999-03-16 PL PL343029A patent/PL194804B1/pl not_active IP Right Cessation
- 1999-03-16 PT PT99907345T patent/PT1062341E/pt unknown
-
2000
- 2000-09-07 IL IL138339A patent/IL138339A/en not_active IP Right Cessation
- 2000-09-12 ZA ZA200004819A patent/ZA200004819B/xx unknown
- 2000-09-15 NO NO20004614A patent/NO328354B1/no not_active IP Right Cessation
-
2001
- 2001-06-06 HK HK01103901A patent/HK1033591A1/xx not_active IP Right Cessation
-
2003
- 2003-11-20 US US10/719,553 patent/US20040091500A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU749749B2 (en) | 2002-07-04 |
DE69939584D1 (de) | 2008-10-30 |
NO20004614D0 (no) | 2000-09-15 |
NO20004614L (no) | 2000-10-26 |
EP1062341A1 (fr) | 2000-12-27 |
ZA200004819B (en) | 2001-05-30 |
NO328354B1 (no) | 2010-02-01 |
US20040091500A1 (en) | 2004-05-13 |
CA2323687C (fr) | 2008-11-25 |
IL138339A0 (en) | 2001-10-31 |
ATE408690T1 (de) | 2008-10-15 |
IL138339A (en) | 2009-06-15 |
KR20010041918A (ko) | 2001-05-25 |
EP1062341B1 (fr) | 2008-09-17 |
ES2313776T3 (es) | 2009-03-01 |
JP2002506648A (ja) | 2002-03-05 |
PL343029A1 (en) | 2001-07-30 |
NZ506665A (en) | 2003-08-29 |
HK1033591A1 (en) | 2001-09-07 |
PT1062341E (pt) | 2008-12-24 |
CN1332029C (zh) | 2007-08-15 |
CN1293710A (zh) | 2001-05-02 |
PL194804B1 (pl) | 2007-07-31 |
HUP0101464A2 (hu) | 2001-08-28 |
WO1999047680A1 (fr) | 1999-09-23 |
AU2714799A (en) | 1999-10-11 |
HUP0101464A3 (en) | 2004-10-28 |
CA2323687A1 (fr) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1062341T3 (da) | Muterede rekombinante allergener | |
ATE414773T1 (de) | Mutante allergene | |
WO2004024097A8 (fr) | Compositions et methodes de traitement de maladies de nature immune | |
WO2004039956A3 (fr) | Compositions et methodes de traitement de maladies liees au systeme immunitaire | |
MXPA04002593A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
MXPA03011985A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
HUP0302965A2 (hu) | Vakcina | |
AU3227700A (en) | Skin sanitizing compositions | |
BG102818A (en) | D-manitol and method for its preparation | |
IL145795A0 (en) | Mutant human cd80 and compositions for and methods of making and using the same | |
MX9708426A (es) | Polipeptido hk2 de variante estable. | |
DE69828179D1 (de) | T-zellimpfung zur behandlung von multiple sclerosis | |
WO2004024072A3 (fr) | Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire | |
WO2001040465A3 (fr) | Compositions et procedes de traitement de maladies d'ordre immunologique | |
MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
TR199700416A2 (xx) | Fluorinlenmi� vitamin D3 analoglar�. | |
DE60134408D1 (de) | Für akzessorische hiv proteine kodierende dna impfstoffe | |
NZ514027A (en) | Cloning and expression of haemophilus somnus transferrin-binding proteins | |
WO2004004649A3 (fr) | Compositions et procedes destines au traitement de maladies liees au systeme immunitaire | |
WO2001016319A3 (fr) | Compositions et procedes pour le traitement de maladies d'ordre immunologique | |
EP1689430A4 (fr) | Mutant de tyrosinase et procedes d'utilisation correspondants | |
IT1294932B1 (it) | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie | |
WO2001048205A3 (fr) | Sequences murines neu et procedes d"utilisation associes |